ATE239499T1 - Protein-disulfid-isomerasen enthaltende pharmazeutische zusammensetzungen - Google Patents

Protein-disulfid-isomerasen enthaltende pharmazeutische zusammensetzungen

Info

Publication number
ATE239499T1
ATE239499T1 AT99957333T AT99957333T ATE239499T1 AT E239499 T1 ATE239499 T1 AT E239499T1 AT 99957333 T AT99957333 T AT 99957333T AT 99957333 T AT99957333 T AT 99957333T AT E239499 T1 ATE239499 T1 AT E239499T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
compositions containing
containing protein
protein disulfide
disulfide isomerases
Prior art date
Application number
AT99957333T
Other languages
English (en)
Inventor
Alberto Bartorelli
Original Assignee
Pharmaproducts Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaproducts Uk Ltd filed Critical Pharmaproducts Uk Ltd
Application granted granted Critical
Publication of ATE239499T1 publication Critical patent/ATE239499T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/52—Isomerases (5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AT99957333T 1998-12-04 1999-12-02 Protein-disulfid-isomerasen enthaltende pharmazeutische zusammensetzungen ATE239499T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998MI002634A IT1303823B1 (it) 1998-12-04 1998-12-04 Composizioni farmaceutiche a base di proteine.
PCT/EP1999/009398 WO2000033861A2 (en) 1998-12-04 1999-12-02 Pharmaceutical compositions containing protein-disulfide isomerases

Publications (1)

Publication Number Publication Date
ATE239499T1 true ATE239499T1 (de) 2003-05-15

Family

ID=11381191

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99957333T ATE239499T1 (de) 1998-12-04 1999-12-02 Protein-disulfid-isomerasen enthaltende pharmazeutische zusammensetzungen

Country Status (7)

Country Link
EP (1) EP1137433B1 (de)
JP (1) JP2002531514A (de)
AT (1) ATE239499T1 (de)
AU (1) AU1507300A (de)
DE (1) DE69907727D1 (de)
IT (1) IT1303823B1 (de)
WO (1) WO2000033861A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10217254A1 (de) * 2002-04-15 2003-10-23 Proteosys Ag Verwendung von Substanzen zur Behandlung von Tumoren
EP1961763A1 (de) * 2007-02-21 2008-08-27 Institut Gustave Roussy Verbindungen zur Regulierung der Aufnahme von CRT, KDEL-Rezeptoren und/oder ERp-57 und ihre Verwendung zur Bewertung der Effizienz von Krebsbehandlungen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798249A (en) * 1996-05-15 1998-08-25 Incyte Pharmaceuticals, Inc. Human protein disulfide isomerase
US5919657A (en) * 1997-04-09 1999-07-06 Incyte Pharmaceuticals, Inc. Nucleic acids encoding human thioredoxin protein; related reagents
US5948646A (en) * 1997-12-11 1999-09-07 Fordham University Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
US6117989A (en) * 1998-03-26 2000-09-12 Incyte Pharmaceuticals, Inc. Human calcium-binding proteins

Also Published As

Publication number Publication date
IT1303823B1 (it) 2001-02-23
EP1137433B1 (de) 2003-05-07
WO2000033861A2 (en) 2000-06-15
ITMI982634A1 (it) 2000-06-05
EP1137433A2 (de) 2001-10-04
WO2000033861A3 (en) 2000-08-10
JP2002531514A (ja) 2002-09-24
AU1507300A (en) 2000-06-26
DE69907727D1 (de) 2003-06-12

Similar Documents

Publication Publication Date Title
BR9607317A (pt) Peptídios e composição farmacêutica
BR9607318A (pt) Peptidos e composição farmacêutica
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
DK1053256T3 (da) Antistoffer mod Dødsreceptor 4 (DR4) og anvendelser deraf
EA199800946A1 (ru) Концентрированный препарат антител
IT1203515B (it) Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono
DE69810612T2 (de) Pharmazeutische Zusammensetzungen mit Plasmaproteinen
ES2053676T3 (es) Formulacion de proteinas plasmaticas y recombinantes en medios de fuerza ionica elevada.
DE69905170T2 (de) Thiazolopyrimidinderivate
PT1212317E (pt) Derivados de indole e sua utilizacao no tratamento de osteoporose entre outras aplicacoes
IS5504A (is) Samsetning virk við meðhöndlun á getuleysi
ATE273388T1 (de) Veränderte menschliche c3-proteine
IL145689A0 (en) Methods
ITMI942663A0 (it) Proteine ricche in idrossiprolina e formulazioni farmaceutiche e cosmetiche che le compongono
AU7423391A (en) Dna constructs for the expression of proteins in the mammary gland of transgenetic mammals
DK1005342T3 (da) Farmaceutiske sammensætninger indeholdende tizoxanid og nitazoxanid
MD970269A (en) Clavulanates
PT723552E (pt) Oligopeptidos derivados de fragmentos de proteina reactiva c
EA200000875A1 (ru) Белки, взаимодействующие с каспазой-8
ATE239499T1 (de) Protein-disulfid-isomerasen enthaltende pharmazeutische zusammensetzungen
DE69831223D1 (de) Gefriergetrocknete zusammensetzung des menschlichen,morphogenen knochenproteins mp52
FI971872A0 (fi) Proteiinikoostumus ja sen valmistus ja käyttö sekä sitä sisältävät valmisteet ja näiden valmistus
DE69518319T2 (de) Verwendung von oberflächenaktiven substanzen zur stabilisierung von peptiden und proteinen zur radiopharmazeutischen verwendung
DE3481420D1 (de) Physiologisch aktives proteinmaterial.
DE69821227D1 (de) Verwendung von papovavirus kapsid-proteinen zur verabreichung therapeutischen agentien in nervzellen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties